Sandra A. Gutcher

523 total citations
9 papers, 397 citations indexed

About

Sandra A. Gutcher is a scholar working on Oncology, Orthopedics and Sports Medicine and Genetics. According to data from OpenAlex, Sandra A. Gutcher has authored 9 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Orthopedics and Sports Medicine and 3 papers in Genetics. Recurrent topics in Sandra A. Gutcher's work include Bone health and treatments (9 papers), Bone health and osteoporosis research (7 papers) and Estrogen and related hormone effects (3 papers). Sandra A. Gutcher is often cited by papers focused on Bone health and treatments (9 papers), Bone health and osteoporosis research (7 papers) and Estrogen and related hormone effects (3 papers). Sandra A. Gutcher collaborates with scholars based in United Kingdom and Ireland. Sandra A. Gutcher's co-authors include Janet E. Brown, Robert E. Coleman, O.P. Purohit, Sue Ellis, J. Lester, C S Thomson, David Dodwell, Janet Horsman, R.A. Hannon and Eugène McCloskey and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Sandra A. Gutcher

9 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra A. Gutcher United Kingdom 7 362 176 146 72 71 9 397
Stephanie Petrone United States 3 452 1.2× 141 0.8× 175 1.2× 202 2.8× 36 0.5× 5 511
Ankur Modi United States 6 273 0.8× 98 0.6× 123 0.8× 60 0.8× 63 0.9× 10 395
Elisabeth Melbinger‐Zeinitzer Austria 6 179 0.5× 50 0.3× 35 0.2× 40 0.6× 64 0.9× 6 211
Dimitra Mihou Greece 6 333 0.9× 150 0.9× 30 0.2× 20 0.3× 91 1.3× 6 383
M. Delforge Belgium 5 202 0.6× 73 0.4× 38 0.3× 10 0.1× 72 1.0× 6 263
Nilesh Mehta United States 5 319 0.9× 71 0.4× 50 0.3× 100 1.4× 82 1.2× 6 389
L. Ciuffreda Italy 8 208 0.6× 119 0.7× 17 0.1× 52 0.7× 96 1.4× 23 333
Mark C. Eddy United States 8 80 0.2× 19 0.1× 23 0.2× 35 0.5× 113 1.6× 11 298
Anastasia Banti Greece 7 229 0.6× 140 0.8× 23 0.2× 18 0.3× 43 0.6× 9 293
Natasha Mithal United Kingdom 8 116 0.3× 8 0.0× 42 0.3× 81 1.1× 48 0.7× 11 265

Countries citing papers authored by Sandra A. Gutcher

Since Specialization
Citations

This map shows the geographic impact of Sandra A. Gutcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra A. Gutcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra A. Gutcher more than expected).

Fields of papers citing papers by Sandra A. Gutcher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra A. Gutcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra A. Gutcher. The network helps show where Sandra A. Gutcher may publish in the future.

Co-authorship network of co-authors of Sandra A. Gutcher

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra A. Gutcher. A scholar is included among the top collaborators of Sandra A. Gutcher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra A. Gutcher. Sandra A. Gutcher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Lester, J., David Dodwell, Janet E. Brown, et al.. (2012). Prevention of anastrozole induced bone loss with monthly oral ibandronate: Final 5 year results from the ARIBON trial. Journal of bone oncology. 1(2). 57–62. 15 indexed citations
2.
Lester, J., David Dodwell, O.P. Purohit, et al.. (2008). OC5. Prevention of anastrozole induced bone loss with monthly oral ibandronate during adjuvant breast cancer therapy: Two year results from the ARIBON study. Cancer Treatment Reviews. 34. 51–52. 2 indexed citations
3.
Lester, J., David Dodwell, O.P. Purohit, et al.. (2008). Use of monthly oral ibandronate to prevent anastrozole-induced bone loss during adjuvant treatment for breast cancer: Two-year results from the ARIBON study. Journal of Clinical Oncology. 26(15_suppl). 554–554. 13 indexed citations
4.
Lester, J., David Dodwell, O.P. Purohit, et al.. (2008). Prevention of Anastrozole-Induced Bone Loss with Monthly Oral Ibandronate during Adjuvant Aromatase Inhibitor Therapy for Breast Cancer. Clinical Cancer Research. 14(19). 6336–6342. 148 indexed citations
5.
Lester, J., Sandra A. Gutcher, Sue Ellis, et al.. (2007). Effect of monthly oral ibandronate on anastrozole-induced bone loss during adjuvant treatment for breast cancer: One-year results from the ARIBON study. Journal of Clinical Oncology. 25(18_suppl). 553–553. 11 indexed citations
6.
Brown, Janet E., et al.. (2007). Prolonged Efficacy of a Single Dose of the Bisphosphonate Zoledronic Acid. Clinical Cancer Research. 13(18). 5406–5410. 54 indexed citations
7.
Brown, Janet E., Sue Ellis, Paul Silcocks, et al.. (2006). Effect of Chemotherapy on Skeletal Health in Male Survivors from Testicular Cancer and Lymphoma. Clinical Cancer Research. 12(21). 6480–6486. 24 indexed citations
8.
Brown, Janet E., J. Lester, Sue Ellis, et al.. (2005). Can an annual infusion of zoledronic acid protect against cancer-treatment induced bone loss (CTIBL)?. Journal of Clinical Oncology. 23(16_suppl). 8023–8023. 1 indexed citations
9.
Brown, Janet E., C S Thomson, Sue Ellis, et al.. (2003). Bone resorption predicts for skeletal complications in metastatic bone disease. British Journal of Cancer. 89(11). 2031–2037. 129 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026